Racial Differences in Mortality Among Medicare Recipients After Treatment for Localized Prostate Cancer

Godley, Paul A.; Schenck, Anna P.; Amamoo, M. Ahinee; Schoenbach, Victor J.; Peacock, Sharon; Manning, Michelle; Symons, Michael; Talcott, James A.

doi:10.1093/jnci/djg094

Cited by 130 publications

(106 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Evidence from existing literature suggests that racial minority groups, especially African American men, have substantially shorter survival after diagnosis of PC compared with Caucasian men (Brawley, Knopf, & Merrill, 1998;Godley et al, 2003;Jones et al, 2008;Ries et al, 2005;Siegel, Naishadham, & Jemal, 2012). Reasons for these survival disparities remain unclear.…”

Section: Introductionmentioning

confidence: 99%

Racial Disparities in Survival After Diagnosis of Prostate Cancer in Kentucky, 2001-2010

et al. 2013

View full text Add to dashboard Cite

Whether the African American race remains a significant predictor of poorer prostate cancer survival after adjusting for other sociodemographic and treatment-related factors remains unclear. We examined whether disparities in survival among 18,900 African American and Caucasian men diagnosed with prostate cancer in Kentucky remained after adjusting for health insurance (payor source), cancer treatment, cancer stage at diagnosis, prostate-specific antigen (PSA) level, smoking status, and Appalachian region. After adjusting for these predictors, African American men living in Kentucky had poorer prostate cancer survival after 5 years (hazard ratio [HR] = 1.33; 95% confidence interval = 1.11, 1.59) and 10 years (HR = 1.39; 95% CI = 1.18, 1.28) of follow-up, and for the entire follow-up period (HR = 1.41; 95% CI = 1.26, 1.65) compared to their Caucasian counterparts. Thus, health insurance status, cancer treatment, cancer stage at diagnosis, PSA level at diagnosis, smoking status, and geographic location did not explain the racial gap in survival in Kentucky.

show abstract

Section: Introductionmentioning

confidence: 99%

Racial Disparities in Survival After Diagnosis of Prostate Cancer in Kentucky, 2001-2010

et al. 2013

View full text Add to dashboard Cite

show abstract

“…We didn't have available data regarding the racial/ethnic distribution of both groups. It's well known that there is a higher PCa incidence and mortality among African Americans (13,14). However, it remains poorly defined the reasons to explain this phenomenon and to what extent racial/ ethnic differences in PCa result from differences in SES.…”

Section: Discussionmentioning

confidence: 99%

8 Socioeconomic Status Is an Independent Predictor of Biochemical Recurrence Among Patients With Prostate Cancer Who Undergo Radical Prostatectomy

Srougi¹,

Antunes²,

Reis³

et al. 2010

Journal of Urology

View full text Add to dashboard Cite

Purpose: Socioeconomic status (SES) may influence cancer characteristics and behavior in several aspects. We analyzed PCa characteristics and behavior among low income uninsured men, and compare them to high income patients with health insurance in a developing country. Materials and Methods: A retrospective case-control study was performed on 934 patients with clinically localized PCa who underwent radical prostatectomy between March, 1999 and July, 2009. Patients were divided in two groups, according to their SES. In group 1 (n=380), all had low income, low educational levels and couldn't afford medical insurance. In group 2 (n=554), all had higher income, higher education and had medical insurance. Results: Patients from group 1 were older, had higher Gleason scores, higher rates of seminal vesicle and bladder neck involvement. The Kaplan Meier disease-free survival curve demonstrated that after a follow-up of four years, about 50% of uninsured patients had biochemical recurrence, versus 21% of insured patients (Log rank test: p < 0.001). A multivariate Cox regression analysis for the risk of disease recurrence demonstrated that only PSA levels, Gleason score, seminal vesicle involvement and SES were statistically significant variables. Patients with a low SES presented 1.8 times the risk of recurrence as compared to patients with a high SES. Conclusions: Patients with low SES were older, presented more aggressive PCa characteristics and a high rate of disease recurrence. A low SES constituted an independent predictor for disease recurrence.

show abstract

“…A incidência de câncer de próstata em afro-americanos revela-se a maior entre todos os grupos étnicos já estudados (GODLEY PA et al, 2003).…”

Section: Nos Estudos Sobre As Diferenças Raciais Nos Estadosunclassified

“…Esta teoria se fundamenta na maior incidência da doença em áreas urbanas e um incremento da taxa de mortalidade. A exposição a substâncias químicas, a produção de dejetos industriais e contaminantes ambientais poderiam contribuir para esta taxa mais elevada (GODLEY PA et al, 2003 Revisão da Literatura -29 …”

Section: Nos Estudos Sobre As Diferenças Raciais Nos Estadosunclassified

See 1 more Smart Citation

Papel do bloqueio androgênico no tratamento do câncer de próstata localmente avançado

Ponte¹

View full text Add to dashboard Cite

Racial Differences in Mortality Among Medicare Recipients After Treatment for Localized Prostate Cancer

Cited by 130 publications

References 44 publications

Racial Disparities in Survival After Diagnosis of Prostate Cancer in Kentucky, 2001-2010

Racial Disparities in Survival After Diagnosis of Prostate Cancer in Kentucky, 2001-2010

8 Socioeconomic Status Is an Independent Predictor of Biochemical Recurrence Among Patients With Prostate Cancer Who Undergo Radical Prostatectomy

Papel do bloqueio androgênico no tratamento do câncer de próstata localmente avançado

Contact Info

Product

Resources

About